As a potential candidate tumor suppressor, loss of heterozygosity or homozygous deletions may occur in genomic area of CSMD334, 35, however, we did not find loss of copy number in genomic regions of CSMD3 in tumor samples compared with normal lung samples (data file 10). Here, CSMD3 is linked to neoplasm.